Conavi Medical (CNVI) Leading and Unique Cardiovascular Imaging Technologies: CEO Tom Looby скачать в хорошем качестве

Conavi Medical (CNVI) Leading and Unique Cardiovascular Imaging Technologies: CEO Tom Looby

Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) This video is produced on behalf of the presenting company. @ConaviMed $CNVI $CNVIF #CNVI #CNVIF #ConvaviMedical #MedTech #HealthTech #MedicalInnovation #ClinicalImaging #HealthcareStocks #CardiovascularImaging https://www.conavi.com/ Conavi Medical is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. The Novasight Hybrid System has 510(k) clearance from the U.S. Food and Drug Administration; and regulatory approval for clinical use from Health Canada, China's National Medical Products Administration, and Japan's Ministry of Health, Labor and Welfare. For more information, visit conavi.com. Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers.